Literature DB >> 28223150

Roles of G protein-coupled estrogen receptor GPER in metabolic regulation.

Geetanjali Sharma1, Franck Mauvais-Jarvis2, Eric R Prossnitz3.   

Abstract

Metabolic homeostasis is differentially regulated in males and females. The lower incidence of obesity and associated diseases in pre-menopausal females points towards the beneficial role of the predominant estrogen, 17β-estradiol (E2). The actions of E2 are elicited by nuclear and extra-nuclear estrogen receptor (ER) α and ERβ, as well as the G protein-coupled estrogen receptor (GPER, previously termed GPR30). The roles of GPER in the regulation of metabolism are only beginning to emerge and much remains unclear. The present review highlights recent advances implicating the importance of GPER in metabolic regulation. Assessment of the specific metabolic roles of GPER employing GPER-deficient mice and highly selective GPER-targeted pharmacological agents, agonist G-1 and antagonists G-15 and G36, is also presented. Evidence from in vitro and in vivo studies involving either GPER deficiency or selective activation suggests that GPER is involved in body weight regulation, glucose and lipid homeostasis as well as inflammation. The therapeutic potential of activating GPER signaling through selective ligands for the treatment of obesity and diabetes is also discussed.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Estrogen; GPER; Inflammation; Insulin resistance; Metabolism; Obesity

Mesh:

Substances:

Year:  2017        PMID: 28223150      PMCID: PMC5563497          DOI: 10.1016/j.jsbmb.2017.02.012

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  104 in total

Review 1.  The link between abdominal obesity, metabolic syndrome and cardiovascular disease.

Authors:  S A Ritchie; J M C Connell
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-11-15       Impact factor: 4.222

Review 2.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

Review 3.  The G-protein coupled estrogen receptor, GPER: The inside and inside-out story.

Authors:  H M Gaudet; S B Cheng; E M Christensen; E J Filardo
Journal:  Mol Cell Endocrinol       Date:  2015-07-17       Impact factor: 4.102

Review 4.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

Review 5.  International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

6.  Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.

Authors:  Luigi Fontana; J Christopher Eagon; Maria E Trujillo; Philipp E Scherer; Samuel Klein
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

Review 7.  G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis.

Authors:  Haifei Shi; Shiva Priya Dharshan Senthil Kumar; Xian Liu
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

8.  Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice.

Authors:  Ulrika E A Mårtensson; S Albert Salehi; Sara Windahl; Maria F Gomez; Karl Swärd; Joanna Daszkiewicz-Nilsson; Anna Wendt; Niklas Andersson; Per Hellstrand; Per-Olof Grände; Christer Owman; Clifford J Rosen; Martin L Adamo; Ingmar Lundquist; Patrik Rorsman; Bengt-Olof Nilsson; Claes Ohlsson; Björn Olde; L M Fredrik Leeb-Lundberg
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

9.  G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.

Authors:  Matthias R Meyer; Natalie C Fredette; Matthias Barton; Eric R Prossnitz
Journal:  J Endocrinol       Date:  2015-08-24       Impact factor: 4.286

Review 10.  Estrogen signaling in metabolic inflammation.

Authors:  Rosário Monteiro; Diana Teixeira; Conceição Calhau
Journal:  Mediators Inflamm       Date:  2014-10-23       Impact factor: 4.711

View more
  39 in total

1.  Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver.

Authors:  Nathan C Winn; Thomas J Jurrissen; Zachary I Grunewald; Rory P Cunningham; Makenzie L Woodford; Jill A Kanaley; Dennis B Lubahn; Camila Manrique-Acevedo; R Scott Rector; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-04       Impact factor: 4.310

2.  A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.

Authors:  Chetana M Revankar; Cristian G Bologa; Richard A Pepermans; Geetanjali Sharma; Whitney K Petrie; Sara N Alcon; Angela S Field; Chinnasamy Ramesh; Matthew A Parker; Nikolay P Savchuk; Larry A Sklar; Helen J Hathaway; Jeffrey B Arterburn; Tudor I Oprea; Eric R Prossnitz
Journal:  Cell Chem Biol       Date:  2019-11-06       Impact factor: 8.116

Review 3.  Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.

Authors:  Matthias Barton; Edward J Filardo; Stephen J Lolait; Peter Thomas; Marcello Maggiolini; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-25       Impact factor: 4.292

Review 4.  Role of Estrogens in the Regulation of Liver Lipid Metabolism.

Authors:  Brian T Palmisano; Lin Zhu; John M Stafford
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 5.  G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis.

Authors:  Geetanjali Sharma; Eric R Prossnitz
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 6.  GPER modulators: Opportunity Nox on the heels of a class Akt.

Authors:  Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-08       Impact factor: 4.292

7.  Cyp1b1 deletion and retinol deficiency coordinately suppress mouse liver lipogenic genes and hepcidin expression during post-natal development.

Authors:  Meghan Maguire; Michele Campaigne Larsen; Yee Hoon Foong; Sherry Tanumihardjo; Colin R Jefcoate
Journal:  Mol Cell Endocrinol       Date:  2017-06-02       Impact factor: 4.102

8.  Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes.

Authors:  Geetanjali Sharma; Chelin Hu; Daniela I Staquicini; Jonathan L Brigman; Meilian Liu; Franck Mauvais-Jarvis; Renata Pasqualini; Wadih Arap; Jeffrey B Arterburn; Helen J Hathaway; Eric R Prossnitz
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 17.956

9.  ERβ agonist alters RNA splicing factor expression and has a longer window of antidepressant effectiveness than estradiol after long-term ovariectomy

Authors:  Xu Hou; Samuel O. Adeosun; Xueying Zhao; Rosanne Hill; Baoying Zheng; Reveena Reddy; Xiao Su; Jeffrey Meyer; Thomas Mosley; Jun Ming Wang
Journal:  J Psychiatry Neurosci       Date:  2019-01-01       Impact factor: 6.186

10.  Phenotypic sexual dimorphism in response to dietary fat manipulation in C57BL/6J mice.

Authors:  Isabel Casimiro; Natalie D Stull; Sarah A Tersey; Raghavendra G Mirmira
Journal:  J Diabetes Complications       Date:  2020-11-28       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.